vs
Byrna Technologies Inc.（BYRN）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Byrna Technologies Inc.的1.0倍（$35.5M vs $35.2M），Byrna Technologies Inc.净利率更高（9.5% vs -304.2%，领先313.8%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 26.0%），Byrna Technologies Inc.自由现金流更多（$8.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 45.5%）
Byrna Technologies Inc.是一家专注于非致命个人安全及自卫产品研发、生产与销售的企业，核心产品包括手持式动能发射器、专用非致命投射弹及相关配件，服务个人消费者、执法机构、私营安保公司及教育机构，核心市场覆盖北美并正拓展全球布局。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BYRN vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $35.2M | $35.5M |
| 净利润 | $3.4M | $-108.1M |
| 毛利率 | 59.8% | 59.8% |
| 营业利润率 | 11.2% | -304.8% |
| 净利率 | 9.5% | -304.2% |
| 营收同比 | 26.0% | 681.7% |
| 净利润同比 | -65.2% | 39.6% |
| 每股收益（稀释后） | $0.14 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $35.2M | $35.5M | ||
| Q3 25 | $28.2M | $5.2M | ||
| Q2 25 | $28.5M | $19.2M | ||
| Q1 25 | $26.2M | $14.7M | ||
| Q4 24 | $28.0M | $4.5M | ||
| Q3 24 | $20.9M | $26.1M | ||
| Q2 24 | $20.3M | $14.4M | ||
| Q1 24 | $16.7M | $13.8M |
| Q4 25 | $3.4M | $-108.1M | ||
| Q3 25 | $2.2M | $-162.3M | ||
| Q2 25 | $2.4M | $-171.9M | ||
| Q1 25 | $1.7M | $-202.5M | ||
| Q4 24 | $9.7M | $-178.9M | ||
| Q3 24 | $1.0M | $-95.8M | ||
| Q2 24 | $2.1M | $-97.5M | ||
| Q1 24 | $17.0K | $-91.4M |
| Q4 25 | 59.8% | 59.8% | ||
| Q3 25 | 60.1% | -183.8% | ||
| Q2 25 | 61.6% | -4.9% | ||
| Q1 25 | 60.8% | -48.0% | ||
| Q4 24 | 62.8% | -181.4% | ||
| Q3 24 | 62.4% | 53.7% | ||
| Q2 24 | 62.0% | 36.2% | ||
| Q1 24 | 57.9% | 19.1% |
| Q4 25 | 11.2% | -304.8% | ||
| Q3 25 | 10.2% | -3327.6% | ||
| Q2 25 | 11.7% | -916.8% | ||
| Q1 25 | 6.5% | -1297.9% | ||
| Q4 24 | 14.6% | -4042.4% | ||
| Q3 24 | 4.0% | -377.1% | ||
| Q2 24 | 9.4% | -697.4% | ||
| Q1 24 | -1.0% | -698.4% |
| Q4 25 | 9.5% | -304.2% | ||
| Q3 25 | 7.9% | -3135.3% | ||
| Q2 25 | 8.5% | -894.2% | ||
| Q1 25 | 6.3% | -1373.3% | ||
| Q4 24 | 34.6% | -3935.5% | ||
| Q3 24 | 4.9% | -367.5% | ||
| Q2 24 | 10.2% | -676.6% | ||
| Q1 24 | 0.1% | -662.4% |
| Q4 25 | $0.14 | $-0.17 | ||
| Q3 25 | $0.09 | $-0.36 | ||
| Q2 25 | $0.10 | $-0.41 | ||
| Q1 25 | $0.07 | $-0.50 | ||
| Q4 24 | $0.42 | $-0.56 | ||
| Q3 24 | $0.04 | $-0.34 | ||
| Q2 24 | $0.09 | $-0.40 | ||
| Q1 24 | $0.00 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $65.8M | $1.1B |
| 总资产 | $84.5M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $15.5M | $743.3M | ||
| Q3 25 | $9.0M | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | $19.3M | $500.5M | ||
| Q4 24 | $25.7M | $594.4M | ||
| Q3 24 | $20.1M | $427.6M | ||
| Q2 24 | $24.8M | $474.3M | ||
| Q1 24 | $24.2M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $65.8M | $1.1B | ||
| Q3 25 | $63.1M | $1.0B | ||
| Q2 25 | $60.1M | $919.1M | ||
| Q1 25 | $56.8M | $933.9M | ||
| Q4 24 | $54.4M | $1.0B | ||
| Q3 24 | $44.5M | $524.6M | ||
| Q2 24 | $45.3M | $584.4M | ||
| Q1 24 | $43.2M | $401.2M |
| Q4 25 | $84.5M | $1.5B | ||
| Q3 25 | $78.6M | $1.4B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | $71.0M | $1.3B | ||
| Q4 24 | $71.9M | $1.4B | ||
| Q3 24 | $59.0M | $726.5M | ||
| Q2 24 | $57.5M | $775.9M | ||
| Q1 24 | $52.7M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | 23.1% | -133.1% |
| 资本支出强度资本支出/营收 | 5.1% | 3.5% |
| 现金转化率经营现金流/净利润 | 2.95× | — |
| 过去12个月自由现金流最近4个季度 | $-9.2M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $9.9M | $-46.1M | ||
| Q3 25 | $-2.3M | $-117.4M | ||
| Q2 25 | $-5.5M | $-76.4M | ||
| Q1 25 | $-3.8M | $-132.0M | ||
| Q4 24 | $7.3M | $-115.4M | ||
| Q3 24 | $-1.4M | $-59.2M | ||
| Q2 24 | $1.9M | $-82.2M | ||
| Q1 24 | $3.9M | $-102.3M |
| Q4 25 | $8.1M | $-47.3M | ||
| Q3 25 | $-4.5M | $-117.6M | ||
| Q2 25 | $-6.4M | $-79.6M | ||
| Q1 25 | $-6.4M | $-133.8M | ||
| Q4 24 | $6.3M | $-116.7M | ||
| Q3 24 | $-2.1M | $-63.8M | ||
| Q2 24 | $1.4M | $-83.4M | ||
| Q1 24 | $3.8M | $-109.0M |
| Q4 25 | 23.1% | -133.1% | ||
| Q3 25 | -16.0% | -2272.5% | ||
| Q2 25 | -22.4% | -413.9% | ||
| Q1 25 | -24.5% | -907.4% | ||
| Q4 24 | 22.5% | -2567.7% | ||
| Q3 24 | -10.0% | -244.6% | ||
| Q2 24 | 7.0% | -578.5% | ||
| Q1 24 | 22.6% | -789.9% |
| Q4 25 | 5.1% | 3.5% | ||
| Q3 25 | 8.0% | 4.7% | ||
| Q2 25 | 3.3% | 16.4% | ||
| Q1 25 | 10.1% | 12.4% | ||
| Q4 24 | 3.4% | 28.6% | ||
| Q3 24 | 3.3% | 17.5% | ||
| Q2 24 | 2.6% | 8.2% | ||
| Q1 24 | 1.0% | 48.2% |
| Q4 25 | 2.95× | — | ||
| Q3 25 | -1.01× | — | ||
| Q2 25 | -2.25× | — | ||
| Q1 25 | -2.27× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | -1.36× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 231.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BYRN
| E Commerce | $23.0M | 65% |
| Wholesale Dealerdistributors | $10.9M | 31% |
| Other | $1.3M | 4% |
RXRX
暂无分部数据
